From our conversations with device companies, investors and surgeons, it's become clear that companies that are able to capitalize on these three aspects of care will be best positioned to maintain or grow their share of the joint reconstruction market.
What portion of new products introduced in joint reconstruction and spine are additively manufactured? To investigate, we tracked product launches and regulatory announcements from January 2015 to 2017.
Happenings like the launch of Stryker's Mako for total knee and the unveil of Zimmer Biomet's future Rosa knee application were the most-talked-about on the exhibit hall floor at AAOS 2017.
Dr. Muratoglu is Director of the Harris Orthopaedic Laboratory and Director of the Technology Implementation Research Center at Massachusetts General Hospital, and Professor of Orthopaedic Surgery at Harvard Medical School. He's also an ORTHOWORLD Member.
Study results indicate that percutaneous intramedullary fixation, such as that provided by the IlluminOss system, can provide stabilization of long bone fractures without open surgery.
Join forces with device makers, suppliers, surgeons and academics from June 13-15 in Chicago to strengthen your knowledge and your network!
Confirm your attendance, today!
This eNewsletter is published by ORTHOWORLD Inc. and is available to
